Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Interaction between MED12 and ΔNp63 activates basal identity in pancreatic ductal adenocarcinoma

    The presence of basal lineage characteristics signifies hyperaggressive human adenocarcinomas of the breast, bladder and pancreas. However, the biochemical mechanisms that maintain this aberrant cell state are...

    Diogo Maia-Silva, Patrick J. Cunniff, Allison C. Schier in Nature Genetics (2024)

  2. Article

    Open Access

    MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting

    Rhabdomyosarcomas (RMS) are pediatric mesenchymal-derived malignancies encompassing PAX3/7-FOXO1 Fusion Positive (FP)-RMS, and Fusion Negative (FN)-RMS with frequent RAS pathway mutations. RMS express the mast...

    Silvia Pomella, Matteo Cassandri, Lucrezia D’Archivio in Nature Communications (2023)

  3. Article

    Open Access

    Targeting of epigenetic co-dependencies enhances anti-AML efficacy of Menin inhibitor in AML with MLL1-r or mutant NPM1

    Monotherapy with Menin inhibitor (MI), e.g., SNDX-5613, induces clinical remissions in patients with relapsed/refractory AML harboring MLL1-r or mtNPM1, but most patients either fail to respond or eventually r...

    Warren Fiskus, Christopher P. Mill, Christine Birdwell in Blood Cancer Journal (2023)

  4. No Access

    Article

    ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation

    The EWS-FLI1 fusion oncoprotein deregulates transcription to initiate the paediatric cancer Ewing sarcoma. Here we used a domain-focused CRISPR screen to implicate the transcriptional repressor ETV6 as a uniqu...

    Yuan Gao, Xue-Yan He, **aoli S. Wu, Yu-Han Huang, Shushan Toneyan in Nature Cell Biology (2023)

  5. No Access

    Article

    BRD8 maintains glioblastoma by epigenetic reprogramming of the p53 network

    Inhibition of the tumour suppressive function of p53 (encoded by TP53) is paramount for cancer development in humans. However, p53 remains unmutated in the majority of cases of glioblastoma (GBM)—the most common ...

    Xueqin Sun, Olaf Klingbeil, Bin Lu, Caizhi Wu, Carlos Ballon, Meng Ouyang in Nature (2023)

  6. Article

    Open Access

    Sirtuin 6 maintains epithelial STAT6 activity to support intestinal tuft cell development and type 2 immunity

    Dynamic regulation of intestinal epithelial cell (IEC) differentiation is crucial for both homeostasis and the response to helminth infection. SIRT6 belongs to the NAD+-dependent deacetylases and has established ...

    **wen **ong, Chenyan Yang, Wei-Qi He, Jiahui Yu, Yue **n in Nature Communications (2022)

  7. No Access

    Article

    OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage

    Tuft cells are a rare chemosensory lineage that coordinates immune and neural responses to foreign pathogens in mucosal tissues1. Recent studies have also revealed tuft-cell-like human tumours2,3, particularly as...

    **aoli S. Wu, Xue-Yan He, Jonathan J. Ipsaro, Yu-Han Huang, Jonathan B. Preall in Nature (2022)

  8. Article

    Open Access

    Comparative optimization of combinatorial CRISPR screens

    Combinatorial CRISPR technologies have emerged as a transformative approach to systematically probe genetic interactions and dependencies of redundant gene pairs. However, the performance of different function...

    Ruitong Li, Olaf Klingbeil, Davide Monducci, Michael J. Young in Nature Communications (2022)

  9. No Access

    Article

    SMARCA4 biology in alveolar rhabdomyosarcoma

    Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in children and phenocopies a muscle precursor that fails to undergo terminal differentiation. The alveolar subtype (ARMS) has the poorest prognosi...

    Narendra Bharathy, Megan M. Cleary, **-Ah Kim, Kiyo Nagamori in Oncogene (2022)

  10. Article

    Open Access

    BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma

    Rhabdomyosarcoma (RMS) is a pediatric malignancy of skeletal muscle lineage. The aggressive alveolar subtype is characterized by t(2;13) or t(1;13) translocations encoding for PAX3- or PAX7-FOXO1 chimeric tran...

    Dominik Laubscher, Berkley E. Gryder, Benjamin D. Sunkel in Nature Communications (2021)

  11. Article

    Open Access

    ACE: a probabilistic model for characterizing gene-level essentiality in CRISPR screens

    High-throughput CRISPR-Cas9 knockout screens are widely used to evaluate gene essentiality in cancer research. Here we introduce a probabilistic modeling framework, Analysis of CRISPR-based Essentiality (ACE),...

    Elizabeth R. Hutton, Christopher R. Vakoc, Adam Siepel in Genome Biology (2021)

  12. Article

    Open Access

    Superior efficacy of co-targeting GFI1/KDM1A and BRD4 against AML and post-MPN secondary AML cells

    There is an unmet need to overcome nongenetic therapy-resistance to improve outcomes in AML, especially post-myeloproliferative neoplasm (MPN) secondary (s) AML. Studies presented describe effects of genetic k...

    Warren Fiskus, Christopher P. Mill, Behnam Nabet, Dimuthu Perera in Blood Cancer Journal (2021)

  13. No Access

    Article

    A pliable ERα cistrome evades therapy

    The transcription factor oestrogen receptor alpha (ERα) has long been targeted for therapeutic benefit in cancer, but drug resistance can emerge through a multitude of mechanisms. A study now reveals how the E...

    **aoli S. Wu, Christopher R. Vakoc in Nature Cell Biology (2020)

  14. No Access

    Article

    Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma

    Core regulatory transcription factors (CR TFs) orchestrate the placement of super-enhancers (SEs) to activate transcription of cell-identity specifying gene networks, and are critical in promoting cancer. Here...

    Berkley E. Gryder, Silvia Pomella, Carly Sayers, **aoli S. Wu in Nature Genetics (2019)

  15. Article

    Open Access

    Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Francisco Caiado, Diogo Maia-Silva, Carolina Jardim, Nina Schmolka in Nature Communications (2019)

  16. Article

    Open Access

    Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection

    Chemotherapy-resistant cancer recurrence is a major cause of mortality. In acute myeloid leukemia (AML), chemorefractory relapses result from the complex interplay between altered genetic, epigenetic and trans...

    Francisco Caiado, Diogo Maia-Silva, Carolina Jardim, Nina Schmolka in Nature Communications (2019)

  17. Article

    Open Access

    SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines

    SMARCA4/BRG1 and SMARCA2/BRM, the two mutually exclusive catalytic subunits of the BAF complex, display a well-established synthetic lethal relationship in SMARCA4-deficient cancers. Using CRISPR-Cas9 screenin...

    Katharina Ehrenhöfer-Wölfer, Teresa Puchner, Cornelia Schwarz in Scientific Reports (2019)

  18. No Access

    Article

    Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3

    Here, we report the fragment-based discovery of BI-9321, a potent, selective and cellular active antagonist of the NSD3-PWWP1 domain. The human NSD3 protein is encoded by the WHSC1L1 gene located in the 8p11-p12 ...

    Jark Böttcher, David Dilworth, Ulrich Reiser, Ralph A. Neumüller in Nature Chemical Biology (2019)

  19. Article

    Author Correction: Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.

    Charles M. Rudin, John T. Poirier, Lauren Averett Byers in Nature Reviews Cancer (2019)

  20. Article

    Open Access

    Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

    Non-genetic drug resistance is increasingly recognised in various cancers. Molecular insights into this process are lacking and it is unknown whether stable non-genetic resistance can be overcome. Using single...

    Charles C. Bell, Katie A. Fennell, Yih-Chih Chan, Florian Rambow in Nature Communications (2019)

previous disabled Page of 2